Advance Search
XU Huachu, LI Feng, YANG Hongguang. Value of Clinical Pulmonary Infection Score in guiding treatment of tigecycline combined with cefoperazone sodium and sulbactam sodium for severe pneumonia patients[J]. Journal of Clinical Medicine in Practice, 2020, 24(19): 48-51. DOI: 10.7619/jcmp.202019014
Citation: XU Huachu, LI Feng, YANG Hongguang. Value of Clinical Pulmonary Infection Score in guiding treatment of tigecycline combined with cefoperazone sodium and sulbactam sodium for severe pneumonia patients[J]. Journal of Clinical Medicine in Practice, 2020, 24(19): 48-51. DOI: 10.7619/jcmp.202019014
shu

Value of Clinical Pulmonary Infection Score in guiding treatment of tigecycline combined with cefoperazone sodium and sulbactam sodium for severe pneumonia patients

  • Department of Critical Medicine, The First People's Hospital of Jiujiang City in Jiangxi Province, Jiujiang, Jiangxi, 332000

More Information
  • Received Date: July 26, 2020
    Graphical Abstract
    • Abstract
  • Objective To investigate the value of Clinical Pulmonary Infection Score(CPIS)in guiding the treatment of tigecycline combined with cefoperazone sodium and sulbactam sodium for severe pneumonia patients. Methods Totally 60 patients with severe pneumonia were selected and randomly divided into two groups, with 30 cases in each group. Control group was treated with antibiotics according to the experience, and observation group was treated with antibiotics under the guidance of CPIS. The drug regimen in both groups was tigecycline combined with cefoperazone sodium and sulbactam sodium. The symptom disappearance rate, application time of antibiotics, levels of inflammatory indexes［C reactive protein(CRP), procalcitonin(PCT), white blood cell count(WBC)］ and adverse reactions were compared between the two groups. Results After 2 weeks of treatment, the fever symptoms disappeared in both groups, and there were no significant differences in the disappearance rate of pulmonary rales and expectoration between the two groups(P>0.05). The application time of antibiotics in the observation group was(7.38±2.66)days, which was significantly shorter than(9.82±2.89)days in the control group(t=3.403, P=0.001). The levels of CRP, PCT and WBC in both groups after treatment were significantly lower than those before treatment(P<0.05). The incidence of adverse reactions in the observation group was significantly lower than that in the control group(P<0.05). Conclusion Under the guidance of CPIS, tigecycline combined with cefoperazone sodium and sulbactam sodium is safe and effective in the treatment of severe - pneumonia patients, which can shorten the medication time and relieve the symptoms of patients.
    • FullText(HTML)
    • References (20)
  • 周欣, 姚高琼, 张成志, 等. 重庆市抗菌药物使用调查及干预前后对比分析研究[J]. 重庆医学, 2017, 46(11): 1508-1510.
    黄丽君, 郑丽贞. 抗菌药物联合用药现状调查与研究[J]. 中国生化药物杂志, 2017, 37(7): 403-405.
    刘华锋, 燕丽, 王磊, 等. 替加环素结合头孢哌酮钠舒巴坦钠治疗多药耐药鲍氏不动杆菌肺部感染患者的临床疗效[J]. 中华医院感染学杂志, 2017, 27(15): 3401-3403

    , 3410.
    LI T, SHENG M Y, GU T Z, et al. In vitro assessment of cefoperazone-sulbactam based combination therapy for multidrug-resistant Acinetobacter baumannii isolates in China[J]. Journal of Thoracic Disease, 2018, 10(3): 1370-1376.
    CHEN C Q, YAN M L, HU C B, et al. Diagnostic efficacy of serum procalcitonin, C-reactive protein concentration and clinical pulmonary infection score in Ventilator-Associated Pneumonia[J]. Medecine Sciences: M/S, 2018, 34(Focus issue F1): 26-32.
    石宏哲, 秦铮, 池卫华, 等. 重症肺炎MSCT图像征象、临床肺部感染评分与病情严重程度的相关性研究[J]. 中国CT和MRI杂志, 2019, 17(7): 79-81.
    中国医师协会急诊医师分会. 中国急诊重症肺炎临床实践专家共识[J]. 中国急救医学, 2016, 36(2): 97-107.
    WONGSURAKIAT P, TULATAMAKIT S. Clinical pulmonary infection score and a spot serum procalcitonin level to guide discontinuation of antibiotics in ventilator-associated pneumonia: a study in a single institution with high prevalence of nonfermentative gram-negative bacilli infection[J]. Ther Adv Respir Dis, 2018, 12: 1753466618760134.
    PFALLER M A, FLAMM R K, DUNCAN L R, et al. Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 18, 386 Gram-negative organisms from Europe and the Asia-Pacific region(2013-2014)[J]. Diagnostic Microbiology and Infectious Disease, 2017, 88(2): 177-183.
    CHEN H, LIU Q, CHEN Z, et al. Efficacy of sulbactam for the treatment of Acinetobacter baumannii complex infection: a systematic review and meta-analysis[J]. J Infect Chemother, 2017, 23(5): 278-285.
    秦又发, 吴雷, 朱永坤, 等. 替加环素联合头孢哌酮-舒巴坦治疗广泛耐药鲍曼不动杆菌医院获得性肺炎临床疗效观察[J]. 中国感染与化疗杂志, 2015, 15(5): 430-433.
    GIAMMANCO A, CALÀ C, FASCIANA T, et al. Global assessment of the activity of tigecycline against multidrug-resistant gram-negative pathogens between 2004 and 2014 as part of the tigecycline evaluation and surveillance trial[J]. mSphere, 2017, 2(1): e00310-e00316.
    CHEN Z, SHI X. Adverse events of high-dose tigecycline in the treatment of ventilator-associated pneumonia due to multidrug-resistant pathogens[J]. Medicine(Baltimore), 2018, 97(38): e12467.
    聂晓莉, 闫春良, 赵秋红, 等. 医院内获得性肺炎抗菌药物的疗效和安全性比较[J]. 中国医院药学杂志, 2015, 35(13): 1225-1227.
    HARADA K, SEKIYA N, KONISHI T, et al. Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation[J]. BMC Infectious Diseases, 2017, 17(1): 638-647.
    GARDNER J G, BHAMIDIPATI D R, RUEDA A M, et al. White blood cell counts, alcoholism, and cirrhosis in pneumococcal pneumonia[J]. Open Forum Infectious Diseases, 2017, 4(2): ofx034.
    ITO A, ISHIDA T, TOKUMASU H, et al. Impact of procalcitonin-guided therapy for hospitalized community-acquired pneumonia on reducing antibiotic consumption and costs in Japan[J]. Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy, 2017, 23(3): 142-147.
    PANDURANGAN A P, ASCHER D B, THOMAS S E, et al. Genomes, structural biology and drug discovery: combating the impacts of mutations in genetic disease and antibiotic resistance[J]. Biochemical Society Transactions, 2017, 45(2): 303-311.
    马莹, 李旺, 陈瑶, 等. 某院鲍氏不动杆菌耐药性与抗菌药物使用强度相关性分析[J]. 中华医院感染学杂志, 2020, 30(5): 648-652.
    陈求凝, 张雪梅, 谢邦贵, 等. 不同抗菌药物对肺部感染新生儿肠道菌群及消化系统影响的研究[J]. 中华医院感染学杂志, 2018, 28(16): 2531-2534.
    • Related Articles

  • Related Articles

    [1]MENG Xiangzhong, WEI Feng, WANG Na, SHI Zhenhua, DING Dongrui. Clinical analysis of plasma procalcitonin and C-reactive protein levels in 65 patients with septic shock[J]. Journal of Clinical Medicine in Practice, 2018, (3): 120-122. DOI: 10.7619/jcmp.201803035
    [2]REN Wenjun, LIU Xiaolan. Value of serum procalcitonin in prognosis diagnosis of patients with sepsis[J]. Journal of Clinical Medicine in Practice, 2016, (21): 48-51. DOI: 10.7619/jcmp.201621015
    [3]LI Zhi. Changes and diagnostic value of serum procalcitonin and C-reactive protein in patients with severe infection in ICU[J]. Journal of Clinical Medicine in Practice, 2016, (5): 70-72. DOI: 10.7619/jcmp.201605021
    [4]ZHNG Geng, DENG Bingqu, ZHAN Daliang. Predictive value of serum procalcitonin in diagnosis and prognosis for aged patients with community-acquired pneumonia[J]. Journal of Clinical Medicine in Practice, 2015, (23): 37-40. DOI: 10.7619/jcmp.201523012
    [5]LIU Chijia, CUI Yuntao, ZHANG Aimin. Change and significance of serum procalcitonin and C-reactive protein levels in cerebral hemorrhage patients complicated with infection[J]. Journal of Clinical Medicine in Practice, 2015, (13): 27-29. DOI: 10.7619/jcmp.201513008
    [6]XU Bin, FAN Zhigang, YANG Yun, XU Zongxian. Application of serum procalcitonin and C-reactive protein detections in the diagnosis of neonatal severe infectious disease[J]. Journal of Clinical Medicine in Practice, 2014, (24): 50-52. DOI: 10.7619/jcmp.201424015
    [7]LI Yuanhua, SONG Xiuchan, QI Yingjing, ZENG Peiyang, WU Suhua, LAI Zhijun, XIE Shufeng. Value of plasma procalcitonin level detection in treatment of pyemia[J]. Journal of Clinical Medicine in Practice, 2014, (15): 155-157. DOI: 10.7619/jcmp.201415054
    [8]CHEN Jun, XHAO Lan, BI Jing. Clinical significance of serum procalcitonin and IL-6 detection in diagnosis and treatment of patients with chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2014, (9): 144-145. DOI: 10.7619/jcmp.201409050
    [9]TANG Haicheng, BO Hongjian, ZHOU Zhixiang, ZHANG Qun, JIANG Yongqian, MA Da. Clinical significance of serum procalcitonin detection in antibiotic treatment of patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2013, (24): 16-19,23. DOI: 10.7619/jcmp.201324005
    [10]YU Lan, ZHANG Jifang, LI Yunfang. Application of cefoperazone/sulbactam sodium in the prevention and treatment of obstetric and gynecological infections[J]. Journal of Clinical Medicine in Practice, 2013, (14): 68-70. DOI: 10.7619/jcmp.201314023

Catalog

    Get Citation
    PDF
    XML
    Article views (404) PDF downloads (15) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return